Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R.

Lancet. 2015 Oct 3;386(10001):1341-52. doi: 10.1016/S0140-6736(15)61074-1.

2.

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R.

Lancet. 2015 Oct 3;386(10001):1353-61. doi: 10.1016/S0140-6736(15)60908-4. Erratum in: Lancet. 2016 Jan 2;387(10013):30.

3.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group)., McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

4.

Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.

Musolino A, Michiara M, Conti GM, Boggiani D, Zatelli M, Palleschi D, Bella MA, Sgargi P, Di Blasio B, Ardizzoni A.

J Clin Oncol. 2012 Jul 1;30(19):2362-8. doi: 10.1200/JCO.2011.37.6434.

PMID:
22585698
5.

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Rondeau V, Pignon JP, Michiels S; MACH-NC collaborative Group..

Stat Methods Med Res. 2015 Dec;24(6):711-29. doi: 10.1177/0962280211425578.

PMID:
22025414
6.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Review.

7.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8.

8.

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.

J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039. Review.

PMID:
20956824
9.

Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures.

Sianesi M, Ceci G, Ghirarduzzi A, Del Rio P, Guazzi A, Pisanelli B, Martella E, Ardizzoni A, Di Blasio B, Arcuri MF.

Ann Ital Chir. 2009 Jul-Aug;80(4):315-8.

PMID:
19967892
10.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group..

Radiother Oncol. 2009 Jul;92(1):4-14. doi: 10.1016/j.radonc.2009.04.014.

PMID:
19446902
11.

The structural role of the zinc ion can be dispensable in prokaryotic zinc-finger domains.

Baglivo I, Russo L, Esposito S, Malgieri G, Renda M, Salluzzo A, Di Blasio B, Isernia C, Fattorusso R, Pedone PV.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):6933-8. doi: 10.1073/pnas.0810003106.

12.

RNA interference in mammalia cells by RNA-3'-PNA chimeras.

Potenza N, Moggio L, Milano G, Salvatore V, Di Blasio B, Russo A, Messere A.

Int J Mol Sci. 2008 Mar;9(3):299-315.

13.

The prokaryotic Cys2His2 zinc-finger adopts a novel fold as revealed by the NMR structure of Agrobacterium tumefaciens Ros DNA-binding domain.

Malgieri G, Russo L, Esposito S, Baglivo I, Zaccaro L, Pedone EM, Di Blasio B, Isernia C, Pedone PV, Fattorusso R.

Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17341-6.

14.

Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity.

Moggio L, Romanelli A, Gambari R, Bianchi N, Borgatti M, Fabbri E, Mancini I, di Blasio B, Pedone C, Messere A.

Biopolymers. 2007;88(6):815-22.

PMID:
17918186
15.

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.

Guarneri V, Frassoldati A, Ficarra G, Puglisi F, Andreetta C, Michelotti A, Cresti N, Boni C, Bisagni G, Berardi R, Battelli N, Santoro A, Banna G, Bottini A, Di Blasio B, Maiorana A, Piacentini F, Giovannelli S, Jovic G, Conte P.

Breast Cancer Res Treat. 2008 Jul;110(1):127-34.

PMID:
17687648
16.

Antiproliferative activity of Pt(II) and Pd(II) phosphine complexes with thymine and thymidine.

Messere A, Fabbri E, Borgatti M, Gambari R, Di Blasio B, Pedone C, Romanelli A.

J Inorg Biochem. 2007 Feb;101(2):254-60.

PMID:
17097738
17.

Distachyasin: A new antioxidant metabolite from the leaves of Carex distachya.

Fiorentino A, D'Abrosca B, Pacifico S, Iacovino R, Mastellone C, Di Blasio B, Monaco P.

Bioorg Med Chem Lett. 2006 Dec 1;16(23):6096-101.

PMID:
16971124
18.

A novel type of zinc finger DNA binding domain in the Agrobacterium tumefaciens transcriptional regulator Ros.

Esposito S, Baglivo I, Malgieri G, Russo L, Zaccaro L, D'Andrea LD, Mammucari M, Di Blasio B, Isernia C, Fattorusso R, Pedone PV.

Biochemistry. 2006 Aug 29;45(34):10394-405.

PMID:
16922516
19.

Solid-phase synthesis of cyclic PNA and PNA-DNA chimeras.

Moggio L, De Napoli L, Di Blasio B, Di Fabio G, D'Onofrio J, Montesarchio D, Messere A.

Org Lett. 2006 May 11;8(10):2015-8.

PMID:
16671770
20.

Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.

Cocconi G, Di Blasio B, Boni C, Bisagni G, Rondini E, Bella MA, Leonardi F, Savoldi L, Vallisneri C, Camisa R, Bruzzi P; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy..

Ann Oncol. 2005 Sep;16(9):1469-76.

Items per page

Supplemental Content

Loading ...
Support Center